Steve Mayer
Cognizant Technology Solutions Corp (CTSH) recently have taken one step ahead with the beta value of 0.97
Cognizant Technology Solutions Corp (NASDAQ: CTSH) open the trading on Wednesday, with great promise as it jumped 1.46% to $74.2, ...
ON Semiconductor Corp (ON) PE Ratio stood at $64.30: Odds are Looking Good After Recent Activity
As on Wednesday, ON Semiconductor Corp (NASDAQ: ON) got off with the flyer as it spiked 1.73% to $49.27, before ...
Pay Attention to this Trade Activity as DENTSPLY Sirona Inc (XRAY) last week performance was -14.10%
DENTSPLY Sirona Inc (NASDAQ: XRAY) flaunted slowness of -1.28% at $10.84, as the Stock market unbolted on Wednesday, before settling ...
Now that Fabrinet’s volume has hit 0.54 million, investors get a glimpse of its size.
A new trading day began on Tuesday, with Fabrinet (NYSE: FN) stock price down -3.84% from the previous day of ...
Spyre Therapeutics Inc (SYRE) volume exceeds 0.53 million: A new investment opportunity for investors
On Tuesday, Spyre Therapeutics Inc (NASDAQ: SYRE) opened higher 5.28% from the last session, before settling in for the closing ...
Vericel Corp (VCEL) soared 5.28 in the last month: It’s impossible to believe the numbers
On Tuesday, Vericel Corp (NASDAQ: VCEL) was 5.28% up from the session before settling in for the closing price of ...
No matter how cynical the overall market is VAALCO Energy, Inc (EGY) performance over the last week is recorded 0.26%
VAALCO Energy, Inc (NYSE: EGY) kicked off on Tuesday, down -4.04% from the previous trading day, before settling in for ...
Green Dot Corp (GDOT)’s latest performance is not what we had anticipated
Green Dot Corp (NYSE: GDOT) on Tuesday, plunged -3.98% from the previous trading day, before settling in for the closing ...
Aurinia Pharmaceuticals Inc (AUPH) is destined for greater heights as its last quarter sales were 73,470 K
A new trading day began on Tuesday, with Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stock price up 5.31% from the previous ...
MoonLake Immunotherapeutics (MLTX) is ready for next Episode as it posted an annual sales of 0 K
On Tuesday, MoonLake Immunotherapeutics (NASDAQ: MLTX) opened higher 8.60% from the last session, before settling in for the closing price ...
